CreatorWeek 2025 to Launch in Macao, Merging Eastern and Western Cultures Through 5-Day Business, Content, and Community Celebration

Macao Government Tourism Office (MGTO)and co-organizers, Branded, will host CreatorWeek Macao 2025 from October 24-28, 2025, focusing on the global creator economy, culture, entertainment, and community. The event aims to highlight Macao's vibrant creative economy and status as a hub for cultural exchange between East and West. https://mma.prnewswire.com/media/2754351/image_818622_27398811.jpg Amid the rapid rise of the global […]

Move Over PSL — Rita’s Apple Butter Concrete Is the New Fall Obsession

From orchard-inspired Apple Butter to classic Pumpkin Pie, Rita's limited-time fall Concretes deliver spoonfuls of cozy flavor Move over sweater weather – it's spoon weather at Rita's Italian Ice & Frozen Custard,the largest Italian Ice concept in the world! This season, Rita's is launching an unforgettable new Concrete that captures the warmth and coziness guests

The Florist Defying Singapore’s Economic Downturn

Floristique, a leading florist in Singapore, has defied the odds in a tough economic climate. From humble beginnings to a thriving enterprise, Floristique's success story is a testament to resilience, innovation, and a passion for keeping bouquets affordable. While many local businesses face unprecedented challenges, with more companies being liquidated in the first half of

Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors

(NasdaqGM:OCS),(Iceland:OCS), Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian Wolf, M.D., Ph.D. appointed as Chief Medical Advisor, Ophthalmology, following the material advancement in retina programs with recent enrollment completion of Phase 3

Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors

Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors GlobeNewswire August 25, 2025 Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian Wolf,

ASIA’S MARITIME POWERHOUSE: MARINTEC CHINA 2025 RETURNS WITH UNPRECEDENTED SCALE

The countdown begins! With just 100 days to go, the maritime world is gearing up for the 22nd edition ofMarintec China, Asia's most influential maritime exhibition, returning to the Shanghai New International Expo Centre (SNIEC) from 2-5 December 2025. https://mma.prnewswire.com/media/2756949/Marintec_China_100_days.jpg This year's edition is set to be the biggest and most impactful yet, featuring: —

Digital Health Market is Estimated to Reach USD 449.19 Billion by 2032 | SkyQuest Technology Consulting

The digital health market is anticipated to increase due to the rising prevalence of chronic diseases worldwide, is a major driver of the digital health market. Digital tools like remote monitoring andtelehealth provide continuous patient care, improve disease management, and reduce hospital visits. SkyQuest Technology Consulting published a report, titled, 'Digital Health Market – Global

Did You Lose Money on Petco Health and Wellness Company, Inc. (WOOF)? Levi & Korsinsky Urges Investors to Act Before August 29, 2025

NEW YORK, NY / ACCESS Newswire / August 25, 2025 / If you suffered a loss on your Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/petco-lawsuit-submission-form?prid=163342&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email

Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology

Total equity and debt raising of ~$90 million provides runway to 2H 2027 Strong support from existing and new investors including SPRIM Global Investments Funds will be used to scale-up production of needle-free vaccination delivery technology Founding CEO David Hoey will transition to Strategic Advisor Company well-advanced in search for new CEO to accelerate commercialisation.

Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology

Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology GlobeNewswire August 25, 2025 Total equity and debt raising of ~$90 million provides runway to 2H 2027 Strong support from existing and new investors including SPRIM Global Investments Funds will be used to scale-up production of needle-free vaccination delivery technology Founding CEO David

Scroll to Top